Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Xavier de Mollerat du Jeu"'
Autor:
Yuanyu Huang, Shuquan Zheng, Zhaoxu Guo, Xavier de Mollerat du Jeu, Xing-Jie Liang, Zhiwei Yang, Hong-Yan Zhang, Shan Gao, Zicai Liang
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 7, Iss 1, Pp 1-14 (2022)
Abstract Small interfering RNA (siRNA) constitutes a promising therapeutic modality supporting the potential functional cure of hepatitis B. A novel ionizable lipidoid nanoparticle (RBP131) and a state-of-the-art lyophilization technology were develo
Externí odkaz:
https://doaj.org/article/dafd5403c9c14261b51101744500d46f
Neutrophils contribute to spontaneous resolution of liver inflammation and fibrosis via microRNA-223
Autor:
Xavier de Mollerat du Jeu, Casey D. Johnson, Nektaria Adronikou, Yun Chin Lin, Hana del Pilar, Josh Boyer, Ariel E. Feldstein, Cristina Llorente, Masahiko Tameda, Carolina Jimenez Calvente
Publikováno v:
Journal of Clinical Investigation. 129:4091-4109
Persistent, unresolved inflammation in the liver represents a key trigger for hepatic injury and fibrosis in various liver diseases and is controlled by classically activated pro-inflammatory macrophages, while restorative macrophages of the liver ar
Publikováno v:
Cell and Gene Therapy Insights. 4:377-384
Autor:
Xavier de Mollerat du Jeu, Liesbeth Peeters, Katarina Farkasova, Rupa R. Sawant, Niek N. Sanders, Joseph Demeester, Stefaan C. De Smedt, Vladimir P. Torchilin, Manfred Ogris, Kevin Braeckmans, Leo A. van Grunsven, Kevin Buyens
Publikováno v:
Vrije Universiteit Brussel
siRNA therapeutics are currently regarded as promising candidates to make a leap forward in the search for treatments of various hard to cure diseases. In order to exploit the full potential of siRNA based therapeutics, development of delivery system
Autor:
Xin Yu, Xiquan Liang, Xavier de Mollerat du Jeu, Jason Potter, Huimin Xie, Shantanu Kumar, Jonathan D. Chesnut, Namritha Ravinder
Publikováno v:
Biotechnology Letters
Objectives To identify the best lipid nanoparticles for delivery of purified Cas9 protein and gRNA complexes (Cas9 RNPs) into mammalian cells and to establish the optimal conditions for transfection. Results Using a systematic approach, we screened 6
Autor:
Frédéric Gachon, Walter Wahli, Thierry Claudel, Nicolas Leuenberger, Ueli Schibler, Xavier de Mollerat du Jeu, Céline Jouffe, Fabienne Fleury Olela, Pascal Gos
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 12, pp. 4794-4799
Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 12, pp. 4794-4799
In mammals, many aspects of metabolism are under circadian control. At least in part, this regulation is achieved by core-clock or clock-controlled transcription factors whose abundance and/or activity oscillate during the day. The clock-controlled p
Autor:
Sean Chang, Xin Yu, Yongchang Ji, Xiquan Liang, Nektaria Andronikou, Xavier de Mollerat du Jeu
Publikováno v:
The Journal of Immunology. 200:179.14-179.14
The successes of chimeric antigen receptor (CAR) T cells in treating blood cancers have highlighted the cell therapy era. However, the difficulty of delivering molecules into immune cells has been an obstacle to more rapid advancement. Here we presen
Autor:
Andronikou Nektaria, Xavier de Mollerat du Jeu, Ariel E. Feldstein, Casey D. Johnson, Akiko Eguchi
Publikováno v:
Journal of hepatology, vol 64, iss 3
Background & Aims Liver fibrosis is the most worrisome feature of non-alcoholic steatohepatitis (NASH). Growing evidence supports a link between hepatocyte apoptosis and liver fibrogenesis. Our aim was to determine the therapeutic efficacy and safety
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::481365aeed0ec944e78cc0a5ca0d2eed
https://europepmc.org/articles/PMC4761314/
https://europepmc.org/articles/PMC4761314/
Publikováno v:
The Journal of Immunology. 198:73.24-73.24
The successful cases of autologous CAR-T cell therapy in leukemia have highlighted the promising future of cell therapy. However, most studies in this field have been using viruses to engineer T cells, which lead to safety concerns. On the other hand
462. Serum Free Clinical Grade Large Scale Lentiviral Production System for Gene Therapy Application
Publikováno v:
Molecular Therapy. 24:S183
Recently, lentiviral vectors have become the center of attention for its use as gene transfer vectors in gene therapy. Current new generation of therapies CAR - T requires the lentiviral vectors as efficient gene transfer tool to express engineered C